Sex-Based Differences of LA: Impact on AF Ablation.
ConditionAtrial Fibrillation (AF)
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorCentro Medico Teknon
About this trial
The aim of the study is to assess sex-related differences in patients who underwent a first ablation procedure for paroxysmal or persistent AF, guided by the personalized ablation strategy of the BY-LAWT protocol. Specifically, to compare anatomical characteristics, procedural parameters, and clinical outcomes between sexes.
Eligibility criteria
Qualifiers
Patients who underwent a first ablation procedure for atrial fibrillation (paroxysmal or persistent).
Availability of an adequate pre-procedural cardiac CT scan for LAWT, LAV and inFAT analysis.
Availability of complete procedural data, including ablation index (AI) values recorded using the SmartTouch catheter (Biosense Webster).
Availability of 12-month follow-up data for efficacy and safety endpoint evaluation.
Disqualifiers
Age < 18 years.
Previous cardiac ablation (including AF ablation or other arrhythmias).
Incomplete data regarding procedural parameters, or follow-up.
Poor quality pre-procedural cardiac MDCT
Trial design
Treatments tested in this trial
- Atrial fibrillation ablation
Treatment groups
700 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov